COVID-19 Vaccine Hesitancy among Patients with Inflammatory Bowel Disease Receiving Biologic Therapies in Kuwait: A Cross-Sectional Study

Background: COVID-19 vaccinations have been shown to be effective in reducing risk of severe infection, hospitalization, and death. They have also been shown to be safe and effective in patients with inflammatory bowel disease (IBD) who are receiving biologic therapies. In this study, we aimed to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Shehab, Mohammad, Zurba, Yasmin, Al Abdulsalam, Ali, Alfadhli, Ahmad, Elouali, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777753/
https://www.ncbi.nlm.nih.gov/pubmed/35062716
http://dx.doi.org/10.3390/vaccines10010055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777753/
https://www.ncbi.nlm.nih.gov/pubmed/35062716
http://dx.doi.org/10.3390/vaccines10010055

Ejemplares similares